Evidence map›Paper›PMID 35023350›Full record

ArticleJournal of the American Heart Association2022

Atrial Fibrillation and Stroke Symptoms in the REGARDS Study.

Meghan Reading Turchioe, Elsayed Z Soliman, Parag Goyal, Alexander E Merkler, Hooman Kamel, Mary Cushman, Orysya Soroka, Ruth Masterson Creber, Monika M Safford

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Discovery ofBiology · 2023
    Article
  7. Racial, ethnic, and sex disparities in atrial fibrillation management: rate and rhythm control.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Meghan Reading TurchioeWeill Cornell Medicine New York NY.ORCID 0000-0002-6264-6320
Elsayed Z SolimanWake Forest School of Medicine Winston-Salem NC.ORCID 0000-0001-5632-8150
Parag GoyalWeill Cornell Medicine New York NY.ORCID 0000-0001-7474-3737
Alexander E MerklerWeill Cornell Medicine New York NY.ORCID 0000-0002-2211-299X
Hooman KamelWeill Cornell Medicine New York NY.ORCID 0000-0002-5745-0307
Mary CushmanLarner College of Medicine at the University of Vermont Burlington VT.ORCID 0000-0002-7871-6143
Orysya SorokaWeill Cornell Medicine New York NY.ORCID 0000-0003-3282-2378
Ruth Masterson CreberWeill Cornell Medicine New York NY.ORCID 0000-0002-4238-9902
Monika M SaffordWeill Cornell Medicine New York NY.ORCID 0000-0002-3060-0563
Cornell University · USUniversity of Vermont · USWake Forest University · US

Funding

VCID and Stroke in a Bi-racial National CohortU01NS041588 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CUSHMAN, MARY, HOWARD, GEORGE · 2002 to 2022
$96.0M
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)U01NS095869 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI BRODERICK, JOSEPH PAUL, KAMEL, HOOMAN · 2017 to 2022
$22.0M
REGARDS - MI StudyR01HL080477 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEVITAN, EMILY B, SAFFORD, MONIKA M · 2006 to 2020
$11.6M
Data-driven shared decision-making to reduce symptom burden in atrial fibrillationR00NR019124 · NINR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TURCHIOE, MEGHAN READING · 2022 to 2024
$732k
Data-driven shared decision-making to reduce symptom burden in atrial fibrillationK99NR019124 · NINR · WEILL MEDICAL COLL OF CORNELL UNIV · PI TURCHIOE, MEGHAN READING · 2020 to 2021
$175k
NHLBI NIH HHS R01 HL080477NINDS NIH HHS U01 NS041588NINDS NIH HHS U01 NS095869NINR NIH HHS K99 NR019124NINR NIH HHS R00 NR019124
6 · The paper itself

Abstract

Background It is unknown if stroke symptoms in the absence of a stroke diagnosis are a sign of subtle cardioembolic phenomena. The objective of this study was to examine associations between atrial fibrillation (AF) and stroke symptoms among adults with no clinical history of stroke or transient ischemic attack (TIA). Methods and Results We evaluated associations between AF and self-reported stroke symptoms in the national, prospective REGARDS (Reasons for Geographic and Racial Differences in Stroke) cohort. We conducted cross-sectional (n=27 135) and longitudinal (n=21 932) analyses over 8 years of follow-up of REGARDS participants without stroke/transient ischemic attack and stratified by anticoagulant or antiplatelet agent use. The mean age was 64.4 (SD±9.4) years, 55.3% were women, and 40.8% were Black participants; 28.6% of participants with AF reported stroke symptoms. In the cross-sectional analysis, comparing participants with and without AF, the risk of stroke symptoms was elevated for adults with AF taking neither anticoagulants nor antiplatelet agents (odds ratio [OR], 2.22; 95% CI, 1.89-2.59) or antiplatelet agents only (OR, 1.92; 95% CI, 1.61-2.29) but not for adults with AF taking anticoagulants (OR, 1.08; 95% CI, 0.71-1.65). In the longitudinal analysis, the risk of stroke symptoms was also elevated for adults with AF taking neither anticoagulants nor antiplatelet agents (hazard ratio [HR], 1.41; 95% CI, 1.21-1.66) or antiplatelet agents only (HR, 1.23; 95% CI, 1.04-1.46) but not for adults with AF taking anticoagulants (HR, 0.86; 95% CI, 0.62-1.18). Conclusions Stroke symptoms in the absence of a stroke diagnosis may represent subclinical cardioembolic phenomena or "whispering strokes." Future studies examining the benefit of stroke symptom screening may be warranted.

Indexed as

Atrial FibrillationIschemic Attack, TransientStrokeAdultAnticoagulantsCross-Sectional StudiesFemaleHumansMiddle AgedPlatelet Aggregation InhibitorsProspective StudiesRisk FactorsAnticoagulantsPlatelet Aggregation Inhibitorsatrial fibrillationembolic strokestrokesymptom assessment

Identifiers

PMID35023350
PMCPMC9238509
OpenAlexW4205921052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.